Serotonin synthesis, release and reuptake in terminals: a mathematical model

<p>Abstract</p> <p>Background</p> <p>Serotonin is a neurotransmitter that has been linked to a wide variety of behaviors including feeding and body-weight regulation, social hierarchies, aggression and suicidality, obsessive compulsive disorder, alcoholism, anxiety, and affective disorders. Full understanding of serotonergic systems in the central nervous system involves genomics, neurochemistry, electrophysiology, and behavior. Though associations have been found between functions at these different levels, in most cases the causal mechanisms are unknown. The scientific issues are daunting but important for human health because of the use of selective serotonin reuptake inhibitors and other pharmacological agents to treat disorders in the serotonergic signaling system.</p> <p>Methods</p> <p>We construct a mathematical model of serotonin synthesis, release, and reuptake in a single serotonergic neuron terminal. The model includes the effects of autoreceptors, the transport of tryptophan into the terminal, and the metabolism of serotonin, as well as the dependence of release on the firing rate. The model is based on real physiology determined experimentally and is compared to experimental data.</p> <p>Results</p> <p>We compare the variations in serotonin and dopamine synthesis due to meals and find that dopamine synthesis is insensitive to the availability of tyrosine but serotonin synthesis is sensitive to the availability of tryptophan. We conduct <it>in silico </it>experiments on the clearance of extracellular serotonin, normally and in the presence of fluoxetine, and compare to experimental data. We study the effects of various polymorphisms in the genes for the serotonin transporter and for tryptophan hydroxylase on synthesis, release, and reuptake. We find that, because of the homeostatic feedback mechanisms of the autoreceptors, the polymorphisms have smaller effects than one expects. We compute the expected steady concentrations of serotonin transporter knockout mice and compare to experimental data. Finally, we study how the properties of the the serotonin transporter and the autoreceptors give rise to the time courses of extracellular serotonin in various projection regions after a dose of fluoxetine.</p> <p>Conclusions</p> <p>Serotonergic systems must respond robustly to important biological signals, while at the same time maintaining homeostasis in the face of normal biological fluctuations in inputs, expression levels, and firing rates. This is accomplished through the cooperative effect of many different homeostatic mechanisms including special properties of the serotonin transporters and the serotonin autoreceptors. Many difficult questions remain in order to fully understand how serotonin biochemistry affects serotonin electrophysiology and vice versa, and how both are changed in the presence of selective serotonin reuptake inhibitors. Mathematical models are useful tools for investigating some of these questions.</p

Dioxygen affinities of some ruthenium(III) schiff base complexes

The synthesis and dioxygen affinities of some ruthenium(III) Schiff base complexes in DMF solution in the presence of different axial bases are reported. The ligands used are bis(salicylaldehyde)ethylenediimine (salen), bis(salicylaldehyde)diethylenetriimine (saldien), bis(picolinaldehyde)-o-phenylenediimine (picoph), bis(picolinaidehyde)ethylenediimine (picen) and bis(picolinaldehyde)diethylenetriimine (picdien). The axial ligands employed are chloride (Cl−), imidazole (Im) and 2-methylimidazole (2-MeIm). From the oxygenation constants it is found that electron donating substituents on the Schiff bases increase the affinity for dioxygen. Equilibrium dioxygen uptake measurements at 278, 288 and 303 K provide values of ΔH° and ΔS° of oxygenation that fall in the range -6.1 to -13.3 kcal mol−1 for ΔH° and -10 to -31 cal deg−1 mol−1 for ΔS°. The dioxygen adducts of RuIII were characterized by electrochemistry, UV-vis, IR and EPR techniques as RuIV superoxo complexes